PCI is a respected industry leader and trusted partner providing a comprehensive range of outsourced pharmaceutical services from early stage development to long term commercial supply
We have launched our new Webflow App and it's available now
Webflow is a market leading technology providing a comprehensive customer support portal which brings many benefits to our clients including access to a wide range of reports updated in real time and available 24/7, enabling more efficient and effective supply management.
PCI Pharma Services Announces Acquisition of Millmount Healthcare and Additional EU Footprint
Comprising 3 GMP approved facilities, Millmount Healthcare is able to offer a full turnkey solution including the sourcing and purchase of components, packaging and tooling design, late stage customization, analytical support services and warehousing.
Core services include: Analytical services, formulation development, clinical trial services, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers may choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.
Q&A with Justin Schroeder, Executive Director, Marketing, Business Development and Design, PCI Pharma Services
The need for clinical trials to meet the requirements of regulators, deliver high-quality data, and come in on budget has led to study designs...
We are pleased to announce the release of a published white paper detailing Domino's study which analyzes potential leachability of ink from coding technologies used in pharmaceutical Serialization activities.
PCI Pharma Services is pleased to announce investment in a considerable expansion of our onsite Cold Chain storage at our Philadelphia site.
PCI Clinical Services has announced the launch of our expedited Clinical packaging, labeling and distribution service PCIFastTrack™. The system delivers Clinical Trial supplies for time critical studies in the shortest possible turnaround.
First Molecule to Complete the Development-to-Launch Cycle within PCI's Contained Manufacturing Facility. PCI Pharma Services has announced its first client product to move from clinical development to US commercial launch.
PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at our center... View Article